![]() |
市场调查报告书
商品编码
1800778
2025 年至 2033 年兽医诊断市场报告(按产品、技术、动物类型、疾病类型、最终用户和地区)Veterinary Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2025-2033 |
2024年,全球兽医诊断市场规模达71亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到130亿美元,2025-2033年期间的复合年增长率(CAGR)为6.97%。北美凭藉其完善的兽医基础设施、日益普及的先进诊断技术以及对动物健康管理的日益重视,占据了市场主导地位。宠物饲养数量的增长、宠物预防性照护需求的增加,以及人们对可在动物和人类之间传播的人畜共患疾病的认识不断提高,是推动市场发展的主要因素。
随着人们日益认识到动物健康的重要性,及时诊断和疾病预防也日益受到重视。宠物主人、畜牧养殖户和兽医专家越来越重视早期发现和定期体检,以确保动物健康、降低治疗费用并提高动物寿命和生产力。此外,政府和业者为加强兽医卫生系统所采取的措施也鼓励人们采用诊断方法。促进疾病监测、强制检测和生物安全的政策强化了诊断在保障公共卫生和动物福利方面的重要性,从而刺激了私人和机构兽医护理环境的需求。此外,自动化、分子工具和资料分析等诊断技术的不断进步,大大提高了兽医检测的效率、精确度和可靠性。这些进步使得疾病检测更加准确、流程更加简化、检测更加便捷,使诊断成为当代兽医护理和管理的关键要素。
对快速准确测试的需求
兽医越来越依赖能够快速且精准地提供结果的诊断工具,以辅助快速做出临床决策。在病情快速发展的情况下,检测结果的延迟可能会危及治疗效果和动物的康復。对快速诊断结果的需求促使人们创造和使用能够在护理点或透过快速实验室处理提供即时资讯的技术。高精度仪器可确保准确的评估,从而减少误诊和多余程序的可能性。这种对快速性和精准性的关注提高了临床效率,增强了客户信任,并促进了患者治疗效果的改善。随着实践中时间紧迫的状况日益普遍,不同的兽医护理环境对能够提供快速可靠资讯的诊断设备的需求日益增长。 2024 年,硕腾宣布在全球推出其新型人工智慧血液分析仪 Vetscan OptiCell(TM),该分析仪将于 2025 年 1 月 25 日至 29 日在奥兰多 VMX 展会上首次亮相。这款无萤幕、基于墨盒的设备结合了黏弹性聚焦和人工智慧,可提供快速、准确的 CBC 结果。
增加兽医教育和临床培训
兽医教育的发展和对临床培训的重视,正在促进诊断技术融入常规兽医实践。目前,兽医学院和培训中心优先培养诊断工具、实验室分析和循证治疗计划的实务经验。这些经验会影响新手兽医的期望和临床行为,因为他们在实践之初就具备扎实的诊断程序基础。因此,诊断技术被视为临床评估和决策的必要工具,而非可有可无。持续教育计画的不断涌现也确保了资深从业者能够及时了解新兴技术和诊断方法。这种持续学习的文化提升了诊断技术在兽医职业中的重要性,并鼓励人们积极采用创新解决方案。教育体係不断强调正确检测的重要性,从而培养了一支更重视诊断的兽医团队。
技术创新和诊断进步
临床生物化学、分子检测和数位影像等领域的持续进步正在提升诊断能力的准确性、快速性和广度。这些进步提高了检测结果的可靠性和精确度,使兽医能够做出更明智的临床决策。此外,与数位平台的整合促进了高效的资料处理、快速的结果分析以及对动物健康状况的长期监测。此外,自动化和增强的可用性使兽医从业者能够更轻鬆地使用诊断工具,有助于高效的实践管理并提高服务品质。随着技术的不断进步,兽医诊断领域正变得越来越复杂,从而能够更早地进行干预并提供个人化的护理。顺应这一趋势,Center Point Bio-Tech 于 2024 年在奥兰多举办的 VMX 2024 上推出了其先进的兽医诊断系统 AlphaION,订单量超乎预期。 AlphaION 结合了人工智慧、自动化以及表面声波 (SAW) 测试等创新技术,以扩展临床诊断能力。它能够对各种动物物种进行更快、更准确、更经济的诊断。
扩大动物保健投资和基础设施
公共和私营部门正在投入更多资源,以加强兽医基础设施建设、推动疾病控制措施并提升诊断能力。这体现在现代实验室的改进、兽医从业人员教育的提升以及先进检测设备的广泛普及。例如,2024年,西孟加拉邦畜牧发展公司在其位于卡尔亚尼的CLART设施推出了一项新的宠物诊断服务。加尔各答及其附近郊区的宠物主人可以在线上预约上门采集样本,并在政府实验室进行检测。该计划还包括在盐湖城和巴拉萨特的固定采集点提供免费检测。强大的基础设施能够提高诊断能力、增强服务提供并保证可靠的品质。随着人们日益认识到动物健康的广泛影响,尤其是在公共卫生、食品安全和经济可行性方面,诊断正成为关键关注点。
对复杂疾病的早期检测需求日益增长
随着人们对动物慢性疾病甚至危及生命的疾病的认识不断提高,兽医和宠物主人正在寻求能够在严重临床症状出现之前发现异常的诊断方法。先进的检测仪器使专业人员能够评估器官功能、识别细胞变化并精准定位指标,从而促进及时、有针对性的干预。这种快速诊断的趋势可以提高治疗效果、减少侵入性操作并改善动物的生活品质。兽医护理向主动性和精准导向的转变凸显了诊断在临床过程中的重要性,促进了各种实践类型中常规和专业检测服务的持续使用。 2024年,玛氏科学与诊断公司(Mars Science & Diagnostics)旗下的Antech公司宣布在北美推出两项新的兽医创新技术,包括AIS RapidRead和Nu.Q(R)犬癌症检测。 AIS RapidRead利用人工智慧提供近乎即时的放射学洞察,而Nu.Q(R)则为犬类提供快速癌症筛检。这两种工具都旨在提高诊断速度、准确性和护理效果。
牲畜健康管理日益受到重视
随着对优质动物性食品的需求不断增长,生产商正逐步利用诊断解决方案来降低疾病风险、提高繁殖效率并维持合规性。透过诊断进行常规健康评估有助于维护生物安全、最大限度地减少疾病造成的经济损失并促进永续的农业方法。这使得诊断技术被纳入畜群健康计划,尤其是在商业化养殖实践中。加强监测和及时发现疾病可以改善准备工作,并减少对紧急护理的依赖。评估畜群整体健康状况、监测表现指标和识别亚临床问题的能力正成为生产者的有用资源。随着全球畜牧业面临着在不损害动物福利的情况下满足食品供应需求的压力,诊断技术作为预防和管理资源的重要性变得越来越重要。
The global veterinary diagnostics market size reached USD 7.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.0 Billion by 2033, exhibiting a growth rate (CAGR) of 6.97% during 2025-2033. North America dominates the market owing to its well-established veterinary infrastructure, rising adoption of state-of-the-art diagnostic technologies, and an increasing emphasis on animal health management. The growing number of pet ownerships, increasing demand for preventive care of pets, and rising awareness about zoonotic diseases, which can be transmitted between animals and humans, are some of the major factors propelling the market.
The growing acknowledgment of the significance of animal health is resulting in heightened focus on prompt diagnosis and disease prevention. Pet parents, livestock farmers, and veterinary specialists are increasingly prioritizing early detection and regular check-ups to ensure health, lower treatment expenses, and enhance animal longevity and productivity. Moreover, initiatives by both the government and industry to enhance veterinary health systems are encouraging the adoption of diagnostics. Policies that promote disease surveillance, compulsory testing, and biosecurity strengthen the importance of diagnostics in safeguarding public health and animal welfare, catalyzing the demand in both private and institutional veterinary care environments. Apart from this, ongoing advancements in diagnostic techniques, such as automation, molecular tools, and data analysis, are greatly enhancing the efficiency, precision, and dependability of veterinary testing. These advancements allow for more accurate disease detection, streamlined processes, and increased accessibility of tests, positioning diagnostics as a key element of contemporary veterinary care and administration.
Demand for Fast and Accurate Testing
Veterinary practitioners are increasingly depending on diagnostic tools that provide swift and precise results to aid prompt clinical decision-making. In rapidly advancing cases, delays in receiving test results can jeopardize treatment efficacy and animal recuperation. The need for quick diagnostic results is leading to the creation and use of technologies that deliver instant information at the point of care or via expedited lab processing. High-precision instruments guarantee accurate evaluations, decreasing the chances of incorrect diagnoses and superfluous procedures. This focus on promptness and precision boosts clinical productivity, increases client trust, and fosters improved patient results. With ongoing time-sensitive situations in practices, the demand for diagnostics that can provide quick and reliable information is growing within different veterinary care environments. In 2024, Zoetis announced the global launch of its new AI-powered hematology analyzer, Vetscan OptiCell(TM), debuting at VMX in Orlando from January 25-29, 2025. The screenless, cartridge-based device combined viscoelastic focusing and AI to deliver rapid, accurate CBC results.
Increase in Veterinary Education and Clinical Training
The development of veterinary education and the focus on clinical training are facilitating the incorporation of diagnostics into routine veterinary practice. Veterinary colleges and training centers currently prioritize practical experience with diagnostic tools, lab analysis, and evidence-based treatment planning. This exposure influences the expectations and clinical behaviors of novice professionals, who begin their practice with a solid grounding in diagnostic procedures. As a result, diagnostics are considered essential rather than optional tools for clinical assessment and decision-making. The rising availability of continuing education programs also ensures that established practitioners stay informed about emerging technologies and diagnostic methods. This culture of continuous learning enhances the importance of diagnostics in the profession and encourages the embrace of innovative solutions. The educational system, by consistently emphasizing the importance of proper testing, fosters a more diagnostics-focused veterinary workforce.
Technological Innovation and Diagnostic Advancements
Ongoing advancements in fields like clinical biochemistry, molecular testing, and digital imaging are enhancing the accuracy, rapidity, and range of diagnostic abilities. These advancements are improving the dependability and precision of test outcomes, allowing veterinarians to make better-informed clinical choices. Additionally, integration with digital platforms facilitates efficient data handling, quick analysis of results, and improved monitoring of animal health over time. Moreover, automation and enhanced usability are making diagnostic tools more available to veterinary practitioners, aiding in efficient practice management and elevated service quality. With the ongoing advancements in technology, the field of veterinary diagnostics is becoming increasingly complex, allowing for earlier interventions and tailored care. In line with this trend, in 2024, Center Point Bio-Tech launched its advanced veterinary diagnostic system, AlphaION, at VMX 2024 in Orlando, surpassing order expectations. AlphaION combined AI, automation, and innovations like surface acoustic wave (SAW) testing to expand in-clinic diagnostic capabilities. It enabled faster, more accurate, and cost-effective diagnostics for various animal species.
Expanding Animal Health Investments and Infrastructure
The public and private sectors are investing more resources to enhance veterinary infrastructure, advance disease control initiatives, and boost diagnostic capabilities. This is evident in the evolution of contemporary laboratories, improved education for veterinary practitioners, and the broad access to sophisticated testing equipment. For example, in 2024, the West Bengal Livestock Development Corporation launched a new pet diagnostic service at its CLART facility in Kalyani. Pet parents in Kolkata and nearby suburbs could book home sample collections online, with testing conducted at the government lab. The initiative included free testing at static collection points in Salt Lake and Barasat. A robust infrastructure enables increased diagnostic capacity, enhanced service delivery, and reliable quality assurance. With the growing recognition of the wider effects of animal health, particularly regarding public health, food safety, and economic viability, diagnostics are emerging as a key focus.
Rising Need for Early Detection of Complex Conditions
With the growing awareness about chronic and possibly life-threatening conditions in animals, veterinarians and pet parents are pursuing diagnostic options that can detect irregularities prior to the onset of serious clinical symptoms. Sophisticated testing instruments allow professionals to assess organ functionality, recognize cellular modifications, and pinpoint indicators that facilitate prompt, focused interventions. This move towards prompt diagnosis enhances treatment results, reduces invasive procedures, and improves the quality of life for animals. The shift towards proactive and precision-oriented veterinary care highlights the significance of diagnostics in clinical processes, promoting continued use of both routine and specialized testing services in various practice types. In 2024, Antech, part of Mars Science & Diagnostics, announced two new veterinary innovations in North America, including AIS RapidRead and the Nu.Q(R) Canine Cancer Test. AIS RapidRead used AI to deliver near-instant radiology insights, while Nu.Q(R) offered rapid cancer screening for dogs. Both tools aimed to improve diagnostic speed, accuracy, and care outcomes.
Growing Focus on Livestock Health Management
With the rising demand for premium animal-based food products, producers are progressively utilizing diagnostic solutions to mitigate disease risk, improve reproductive efficiency, and maintain regulatory compliance. Routine health evaluations via diagnostics aid in preserving biosecurity, minimizing financial losses from diseases, and promoting sustainable agricultural methods. This is resulting in the incorporation of diagnostics into herd health initiatives, especially in commercial farming practices. Enhanced monitoring and prompt disease detection lead to improved preparation and decreased dependence on urgent care options. The capability to assess general herd health, monitor performance metrics, and identify subclinical issues is emerging as a useful resource for producers. As the global livestock sector faces pressure to satisfy food supply demands without jeopardizing animal welfare, the importance of diagnostics as a preventive and management resource is becoming more vital.
Kits and reagents dominate the market
Kits and reagents play a crucial role in veterinary diagnostics and provide essential tools and substances for conducting various diagnostic tests. They include pre-packaged reagents and instructions for conducting tests, such as enzyme-linked immunosorbent assays (ELISAs) or polymerase chain reaction (PCR) assays. The reagents in these kits are designed to detect specific pathogens or disease markers, allowing veterinarians to diagnose infectious diseases spontaneously and accurately in animals. They are also used to measure parameters, such as complete blood counts, blood chemistries (including liver and kidney function), electrolyte levels, and blood clotting abilities. They assist in detecting abnormalities, such as the presence of bacteria, parasites, blood, or abnormal levels of certain chemicals or metabolites.
Clinical biochemistry holds the largest share in the market
Clinical biochemistry is a fundamental component of veterinary diagnostics that involves the analysis of blood and other body fluids to assess the physiological and biochemical status of animals. It provides valuable information about organ function, metabolic processes, and the presence of diseases or abnormalities. It helps measure a wide range of parameters, including enzymes, electrolytes, proteins, metabolites, hormones, and waste products. It encompasses various tests, which are conducted using specialized laboratory equipment and reagents. It also focuses on providing quantitative data that helps veterinarians in the diagnosis, monitoring, and treatment of various conditions. Furthermore, by evaluating the levels of specific analytes in the blood, such as liver enzymes, kidney function markers (creatinine), glucose, albumin, and electrolytes (sodium and potassium), clinical biochemistry aids in the detection of organ dysfunction, nutritional imbalances, endocrine disorders, and metabolic abnormalities in animals.
Livestock animals hold the maximum share of the market
Livestock animals, such as cattle, pigs, sheep, and poultry, require veterinary diagnostics as it helps identify and diagnose diseases effectively. Early detection is crucial for implementing appropriate control measures to restrict the spread of infectious diseases within herds or flocks. Besides this, diagnostic tests enable veterinarians to accurately identify the causative agents, determine the extent of disease prevalence, and guide the implementation of effective treatment and preventive strategies. Veterinary diagnostic testing also helps assess the health and productivity of individual animals and the overall herd or flock. By monitoring various parameters, such as blood chemistry, fecal quality, and growth rates, veterinarians can identify and address health issues that may affect production efficiency, including nutritional deficiencies, parasitic infections, metabolic disorders, and respiratory diseases.
Non-infectious diseases account for the majority of market share
Veterinary diagnostics play a crucial role in identifying infectious diseases in animals, as accurate and timely diagnosis is essential for appropriate treatment and control measures. It is essential for disease surveillance and monitoring in animal populations. By conducting diagnostic tests on individual animals or within herds or flocks, veterinarians can assess the prevalence, spread, and impact of infectious diseases. It also aids in identifying various zoonotic diseases in animals, helping prevent or minimize the transmission of pathogens from animals to humans. By diagnosing and managing infectious diseases in animals, veterinary diagnostics contribute to protect public health and prevent the spread of zoonotic infections.
Reference laboratories hold the largest share in the market
Reference laboratories play a vital role in veterinary diagnostics by providing specialized and advanced diagnostic services to support veterinarians, clinics, and research institutions. They are equipped with state-of-the-art technology, highly trained personnel, and expertise in a wide range of veterinary diagnostic disciplines. They offer a comprehensive number of diagnostic tests that may not be available at local veterinary clinics or laboratories. They often possess a broader test menu and the capacity to perform essential tests that require specialized equipment, techniques, or expertise. Reference laboratories can perform highly specific and sensitive tests to detect infectious agents, identify genetic disorders, diagnose complex diseases, and assess the overall health status of animals.
North America exhibits a clear dominance, accounting for the largest veterinary diagnostics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share due to the increase in veterinary specialty practices and referral centers. Besides this, the rising focus on pet health and wellness and advanced veterinary medicine is propelling the growth of the market.
Another contributing aspect is the increasing demand for preventive healthcare, early disease detection, and personalized treatment options to ensure their pets lead long and healthy lives is offering a favorable veterinary diagnostics market outlook.
Asia Pacific is estimated to expand further in this domain due to rising adoption of pets among millennials. Besides this, the increasing expansion of livestock and aquaculture industries is bolstering the growth of the market.
Key market players in the market are implementing various strategies and initiatives to improve their business. They are investing in research and development (R&D) activities to innovate and develop new diagnostic technologies, tests, and products. They are also focusing on improving the accuracy, efficiency, and speed of veterinary diagnostic tests, as well as expanding the range of diseases and conditions that can be diagnosed. Top companies are actively pursuing strategic partnerships and acquisitions to expand their product offerings, geographical reach, and market share. They are also providing telemedicine services to pet owners, comprising of consultation, monitoring, and remote diagnostic in certain scenarios. Leading companies are embracing artificial intelligence (AI), machine learning (ML), and molecular diagnostics to improve their product offerings and service delivery.